Your browser doesn't support javascript.
loading
Efficacy and safety of dose escalation of tofacitinib in refractory anti-MDA5 antibody-positive dermatomyositis.
Ida, Tomoaki; Furuta, Shunsuke; Takayama, Asuka; Tamura, Jun; Hayashi, Yuki; Abe, Kazuya; Kurihara, Syunjiro; Ishikawa, Junichi; Iwamoto, Taro; Ikeda, Kei; Suzuki, Kotaro; Nakajima, Hiroshi.
Afiliação
  • Ida T; Department of Allergy and Clinical Immunology, Chiba University, Chiba, Chiba, Japan.
  • Furuta S; Department of Allergy and Clinical Immunology, Chiba University, Chiba, Chiba, Japan shfuruta@chiba-u.jp.
  • Takayama A; Department of Allergy and Clinical Immunology, Chiba University, Chiba, Chiba, Japan.
  • Tamura J; Department of Allergy and Clinical Immunology, Chiba University, Chiba, Chiba, Japan.
  • Hayashi Y; Department of Allergy and Clinical Immunology, Chiba University, Chiba, Chiba, Japan.
  • Abe K; Department of Allergy and Clinical Immunology, Chiba University, Chiba, Chiba, Japan.
  • Kurihara S; Department of Allergy and Clinical Immunology, Chiba University, Chiba, Chiba, Japan.
  • Ishikawa J; Department of Allergy and Clinical Immunology, Chiba University, Chiba, Chiba, Japan.
  • Iwamoto T; Department of Allergy and Clinical Immunology, Chiba University, Chiba, Chiba, Japan.
  • Ikeda K; Department of Allergy and Clinical Immunology, Chiba University, Chiba, Chiba, Japan.
  • Suzuki K; Department of Allergy and Clinical Immunology, Chiba University, Chiba, Chiba, Japan.
  • Nakajima H; Department of Allergy and Clinical Immunology, Chiba University, Chiba, Chiba, Japan.
RMD Open ; 9(1)2023 01.
Article em En | MEDLINE | ID: mdl-36593080

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Dermatomiosite / Imunossupressores Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: RMD Open Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Japão

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Dermatomiosite / Imunossupressores Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: RMD Open Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Japão